34R-21735-45967
4 vaccinations
2 coded responses
54 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 280 / NC
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Pfizer-BioNTech
- 2021-03-04
- 2021-03-05
-
2021-03-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
-
2021-03-18
Survey response — day 14, dose 1MedDRA: Fatigue, Headache, Nausea, Vertigo — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Headache, nausea, fatigue, vertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
-
2021-03-26
Dose 2 — Pfizer-BioNTech
-
2021-03-26
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-27
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Burning sensation at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-06-25
- 2021-09-24
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, NauseaAdult check-in
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, NauseaAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-10
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2022-01-03
- 2022-04-04
-
2022-09-08
Dose 4 — Pfizer-BioNTech
-
2022-09-08
Health check-in — day 0, dose 4Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2022-09-09
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
- 2022-09-10
-
2022-09-11
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2022-09-12
-
2022-09-13
Health check-in — days 1–6 daily, dose 4Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
-
2022-09-17
Health check-in — day 7, dose 4Feeling: Fair · Fatigue or tiredness, Nausea, Abdominal painAdult check-in
- 2022-09-22
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-12-09
- 2023-03-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-09-08 | Pfizer-BioNTech | No |
Free text
Release 5 — day 14, dose 1
Symptoms: Headache, nausea, fatigue, vertigo
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Burning sensation at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release